Hyperpolarized Xe129 for Coronavirus

University of Kansas Medical Center, Kansas City, KS
CoronavirusHyperpolarized Xe129 - Drug
All Sexes

Study Summary

This trial will help researchers understand how different levels of COVID-19 severity affect pulmonary function and how quickly patients recover.

Eligible Conditions
  • Coronavirus

Treatment Effectiveness

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 6-months

Ventilation Defect Percentage

Trial Safety

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

1 Treatment Group

COVID-19 Survivors
1 of 1

Experimental Treatment

20 Total Participants · 1 Treatment Group

Primary Treatment: Hyperpolarized Xe129 · No Placebo Group · Phase 1

COVID-19 Survivors
Experimental Group · 1 Intervention: Hyperpolarized Xe129 · Intervention Types: Drug

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 6-months

Who is running the clinical trial?

University of Kansas Medical CenterLead Sponsor
413 Previous Clinical Trials
160,721 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 0 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Frequently Asked Questions

What additional investigations have explored the effects of Hyperpolarized Xe129?

"There are currently 15 Hyperpolarized Xe129 trials in progress, none of which are at their final stage. The majority of these experiments take place in Philadelphia but span across 21 medical locations." - Anonymous Online Contributor

Unverified Answer

Are healthcare professionals authorized to use Hyperpolarized Xe129 in treatment?

"Due to the limited amount of research data available, Hyperpolarized Xe129 has been given a safety rating of 1. As this is a Phase 1 trial, there is minimal evidence for efficacy and safety at present." - Anonymous Online Contributor

Unverified Answer

Are there any open slots left for participants in this research?

"Verified. Information hosted on clinicaltrials.gov confirms that this research endeavour, which was originally launched on February 22nd 2021, is currently recruiting individuals for participation. 20 persons need to be recruited from 1 medical centre." - Anonymous Online Contributor

Unverified Answer

How many participants are engaged in this trial?

"Affirmative. The records on clinicaltrials.gov verify that recruitment for this medical trial is still active since it was created in February 2021 and recently updated in August 2022. Currently, the research team needs to acquire 20 participants from a single facility." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.